In contrast, decreased expression of NNMT was found in bladder urothelial carcinoma (BLCA), breast invasive carcinoma (BRCA), cholangiocarcinoma (CHOL), kidney chromophobe (KICH), liver hepatocellular carcinoma (LIHC), lung squamous cell carcinoma (LUSC), and thyroid carcinoma (THCA) (Figure 1(b)). The gene discussed is NNMT; the disease is bladder transitional cell carcinoma.